BN201 SAD MAD Study in Healthy Subjects

NCT03630497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Optic Neuritis
Optic; Neuritis, With Demyelination

Interventions

DRUG: Comparison of BN201 treatment with Placebo

Sponsor

Accure Therapeutics

Collaborators

[object Object]